AST Experts Weigh in on the State of Automated Solutions in 2026
What are the current key trends and technologies at the forefront of pharmaceutical manufacturing automation? How has the revised Annex 1 influenced the industry-wide adoption
Principal CQV Engineer, Jason Rossi, on 10 Common Challenges in Facility Design for Cell and Gene Therapy Production
What are the common pitfalls and solutions when designing a facility for cell and gene therapy production? Cell and gene therapies have led to a
Pharma 4.0 Solutions for Sterile Drug Manufacturing
AST CTO Steven Ng offers a primer on Pharma 4.0 solutions, details the use of digital twin technology for multi-format fill-finish systems, and explains how
QbD Principles: Designing a Manufacturing Operation Around Your Drug Product
AST’s Principal CQV Engineer Jason Rossi discusses how a systematic approach, “Quality by Design”, informs global regulation and how it’s used as a technical design
The Medicine Maker: Worst-Case Scenarios and Ideal Facilities in Fill-Finish
Josh Russell, VP of Technical Sales at AST, was featured in The Medicine Maker as part of a two-part series exploring trends, best practices, and the future
The Medicine Maker: Fill-Finish: The Easy Step? Think Again
Josh Russell, VP of Technical Sales at AST, was featured in The Medicine Maker as part of a two-part series exploring trends, best practices, and the future
The Importance of Prioritizing Annex 1 and First Air:
First Air, as a concept, is a major update in the revised Annex 1, as the document continues the global push towards harmonization of regulatory
Configuration Vs. Customization: The AST Approach to Aseptic Processing – Pharma Technology Focus
Pharma Tech Focus Magazine recently highlighted AST’s modular approach to providing aseptic processing solutions. A key element of this approach is offering full service through various turnkey
AST CTO Steven Ng on Isolator Design
AST’s approach to designing isolator technology began by listening to our customers and striving to create not only the best solution available, but the best
Executive Interview: American Pharmaceutical Review
Josh Russell, VP of Technical Sales, explains what differentiates AST’s innovative fill-finish isolator technology, explains the role of modular, turnkey technology in improving speed to